Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kaleido Biosciences
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be male or female, ≥18 and ≤75 years of age
Confirmed diagnosis of UC (\>6 months) by endoscopy
Mild-to-moderate UC with at least 4 weeks of UC symptomatology prior to screening
Stable medication regimen for at least 2 weeks prior to screening, if on medication for UC
You may not be if
Possible or confirmed diagnosis of Crohn's disease or indeterminate disease
History of isolated distal proctitis
Use of any antidiarrheal medications within the last 1 week prior to screening
Antibiotic treatment within the past 28 days prior to screening
Any non-UC related immunosuppressive medications other than purine analogs. Systemic corticosteroids including prednisone \> 10 mg per day are excluded.
Major intra-abdominal surgery related to the bowel within 24 weeks prior to the screening period and/or planned invasive surgery/hospitalization during the study
Major medical comorbidities, or other conditions in the opinion of the PI, that might impact the patient's safety or compliance, or the interpretation of the study results
Treatment with any other investigational drugs within 28 days prior to the screening visit
Clareo Health | A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function
